• Aleafia Health Inc. (AH) has appointed two new independent directors
  • The company hired Lu Galasso and Carlo Sistilli to its Board
  • Galasso will be appointed to the strategic planning committee
  • Sistilli will be appointed to the audit committee
  • Aleafia Health Inc. is up 1.41 per cent to C$0.72 per share

Aleafia Health Inc. (AH) has appointed two new independent directors.

The company hired Lu Galasso and Carlo Sistilli to its Board.

Galasso will be appointed to the strategic planning committee and Sistilli will be appointed to the audit committee.

“I would like to welcome Lu and Carlo to our Board,” said acting chair Lea Ray.

“Their collective professional experience will bring unique skills to the board that will serve Aleafia Health well in its continued growth.”

Galasso is a Chartered Professional Accountant, CA, CPA and holds the Institute of Corporate Directors ICD.D designation.

He is also a partner with the Zzen Group of Companies, a company in the real estate and manufacturing sectors, where he is the CFO and head of strategic developments for the manufacturing operations.

Sistilli is a Chartered Professional Accountant and a Certified Management Accountant, CPA, CMA. As Chief Financial Officer and member of the Senior Management team of Arista Homes, Sistilli played a key role in overall operations including evaluation of mergers and acquisitions.

Prior to Arista, Sistilli co-founded and served as CFO, member of the M&A team and member of the Board of Directors of an Internet start-up company, helping to take the company public on the Alberta Ventures Exchange.

Aleafia Health is a vertically integrated and federally licensed Canadian cannabis company offering cannabis health and wellness services and products in Canada and in international markets.

Aleafia Health Inc. is up 1.41 per cent to C$0.72 per share.

More From The Market Online

Buzz on the Bullboards: A recap of recent activity and stocks in focus

After a major sell-off, stock markets have been on edge, monitoring corporate earnings to gauge the direction of the economy.

Unsung profits: Three microcap stocks with a strong case for value

A key factor behind picking winning microcap value stocks is identifying dislocations between company performance and market perception.

The Market Online’s Weekly Cannabis Report – April 19, 2024

Cannabis news this week: Canopy Growth shareholders overwhelmingly voted to approve a new class of exchangeable shares.

Buzz on the Bullboards: Challenges amid inflation and geopolitical tensions

Canadian and U.S. stock markets grapple with a host of challenges, from surging inflation data to escalating tensions in the Middle East.